Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of front-line systemic treatment outcomes in POEMS finds ASCT highly efficacious w/ 5- and 10-yr OS of 100% & 90.7%, respectively; PFS of 76.5% and 60.0%; complete VEGF and/or heme response associated w/ lower relapse․”
Title: Front-line systemic treatment outcomes in POEMS syndrome
Authors: Oliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, Nicole Japzon, Ryan Keh, Stephen Keddie, Ashu Wechalekar, Amy Kirkwood, Aisling Carr, Michael Lunn, Shirley D’Sa, Jonathan Sive
You can read the Full Article in British Journal of Haematology.
You can find other articles featuring Robert Orlowski on OncoDaily.
